Ledger.Open graph →
SEC Form D · filed June 12, 2015

Vigeo Therapeutics, Inc

Offering
$10.0M
Sold
$2.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (7)

Peter B. Finn · Boston, MAExec · DirectorJason Dinges · Newton Center, MADirectorEric M. Siegal · CHICAGO, ILExec · DirectorStephanie O'Brien · Plano, TXDirectorDaniel M. Rosenbloom · CHICAGO, ILExec · DirectorJason Dinges · Newton, MADirectorStephanie O'Brien · Berkeley, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗